• Develop and communicate disease concepts that support current and future compounds. Identified and managed investigator initiated trials. Support development of pipeline compounds and product life cycle management. • Collaborated with New Product Planning and Clinical Development to facilitate interactions with expert thought leaders for current and future development initiatives.• Provided leads to Licensing and Acquisition to identify corporate partners and new compounds.• Managed Investigator Initiated studies • Supported Clinical Operations with trial site recommendations

• Initiated development of Neurology Medical Affairs. • Along with the Vice President of MA Neurology, developed job description, hired MSL team, developed program SOPs, metrics, and guidelines. • Represented Medical Affairs for Medical (MRC), Promotional (PRC) and Grant (GRC) Review Committees. • Developed the Medical Information Letters and identified key reprints provided upon request to clinicians. Engaged a vendor for the distribution and management of documents to the requestor.

• Develop and communicate disease concepts that support current and future compounds. Identified and managed investigator initiated trials. Support development of pipeline compounds and product life cycle management. • Collaborated with New Product Planning and Clinical Development to facilitate interactions with expert thought leaders for current and future development initiatives.• Provided leads to Licensing and Acquisition to identify corporate partners and new compounds.• Participated in training courses with two new members of the MSL team.• Managed Investigator Initiated studies • Supported Clinical Operations with trial site recommendations

Provided clinical and scientific information, resources, and services to KOLs. Identified and managed sites and investigators for clinical experience trials. Cross-functional participation with teams supporting the development of pipeline compounds. • Supported marketing with launch activities (Luvox CR), advisory boards, speaker training, sales training, for successful product launch.• Member of the Clinical Development team (JZP-7/RLS) representing Medical Affairs. Participated on advisory consultant meetings, and project management meetings.• Supported other PII/PIII pipeline initiatives.• Worked closely with New Product Planning to identify new reformulation opportunities in selected disease states, identified and engaged disease experts with CDA/Consulting agreements in support of this group. • Worked with Licensing and Acquisition to identify corporate partners, new compounds, and technologies.

Supported product lifecycle management from early clinical development (PII) through product commercialization. Played a leadership role to help prepare the compound, the healthcare community, and the organization for success.• ADHD Franchise – Product Team Lead: Represented Scientific Operations on a cross-functional team for Medical Affairs, ClinOps, MedInfo, Marketing/Brand Franchise. Developed initial training and on-going educational initiatives for SciOps. Reviewed and approved research proposals. Developed and supported brand launch for Medical Affairs, planned and conducted Advisory Boards, developed medical marketing plans, and speaker training• Functioned as lead for several national meetings (APA, AAN, etc). Organized coverage of key sessions, posters, and coordinated KOL interactions with US/Global Medical Affairs• Developed and executed national and regional team meetings, including agenda, inviting guest speakers (internal and external), assignments for colleagues, etc.• Served as internal liaison to Global Clinical Development and Medical Affairs• Developed clinical and preclinical slide decks consistent with products and disease states

Established and maintained collaborative relationships with key academic Neurology, Psychiatry, and Neuroscience thought leaders. Liaison with internal company elements (Discovery, Clinical Development, BD&L, and Marketing) with a strategic product and disease concept focus, identifying areas for collaboration for both internal and external clients. Preclinical and clinical development of product/disease concepts to expand clinical utility through conveying information, education, and awareness.• Prepared market for introduction of pramipexole, a Parkinson’s compound• Designed, developed and implemented training curricula for MSL-CNS • ‘Brain to Motion’ 1996–1997- Proposed and developed a training CD-ROM on Parkinson's Disease for MSL that has been utilized by sales and medical schools• ‘Connections’ 1999-2000. Proposed and managed development of an educational/training CD-ROM on norepinephrine and depression

General sales to Speciality Sales 1974 - 1982Regional Manager (Speciality & Institutional Sales) 1982 - 1988